NVO (Novo Nordisk AS) Accumulated Depreciation : $0 Mil (As of Mar. 2025)

View and export this data going back to 1981. Start your Free Trial

What is Novo Nordisk AS Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Novo Nordisk AS's quarterly accumulated depreciation increased from Sep. 2024 ($0 Mil) to Dec. 2024 ($-7,357 Mil) but then stayed the same from Dec. 2024 ($-7,357 Mil) to Mar. 2025 ($0 Mil).

Novo Nordisk AS's annual accumulated depreciation increased from Dec. 2022 ($-6,373 Mil) to Dec. 2023 ($-6,968 Mil) and increased from Dec. 2023 ($-6,968 Mil) to Dec. 2024 ($-7,357 Mil).

Novo Nordisk AS Accumulated Depreciation Historical Data

The historical data trend for Novo Nordisk AS's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Accumulated Depreciation Chart

Novo Nordisk AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-5,954.97

-6,157.88

-6,372.72

-6,967.58

-7,356.82

Novo Nordisk AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-7,356.82	-

Novo Nordisk AS Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Novo Nordisk AS Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Novo Nordisk AS's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (NYSE:NVO) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

NONOF:USA NOVOB:Mexico NVO:Mexico 0TDD:UK NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NOV:Germany NOVA:Germany NOV:Germany NOV:Germany NOVA:Germany NVON:Canada N1VO34:Brazil NOV:Bulgaria NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, 2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.